ライフサイエンスコーパス: trypsin inhibitor

1 ked to the heavy chain (HC) 1 of inter-alpha-trypsin inhibitor.

2 ation sites in the protein bovine pancreatic trypsin inhibitor.

3 fragment size and both CD44 and inter-alpha-trypsin inhibitor.

4 hibitors (FUT-175 or MPI-0442352) or soybean trypsin inhibitor.

5 chymotrypsin despite the presence of Kunitz trypsin inhibitor.

6 ted in mice with higher pancreatic levels of trypsin inhibitor.

7 etween tick anticoagulant peptide and bovine trypsin inhibitor.

8 plasmin and was readily inhibited by soybean trypsin inhibitor.

9 athway coagulation was suppressed using corn trypsin inhibitor.

10 that of native BPTI, and to be a functional trypsin inhibitor.

11 gth of interactions of the bovine pancreatic trypsin inhibitor.

12 us reactivation of reduced bovine pancreatic trypsin inhibitor.

13 ed with the heavy chains (HC) of inter-alpha-trypsin inhibitor.

14 -4 is 8.6 times higher than purified soybean trypsin inhibitor.

15 either cell-surface HA or serum inter-alpha-trypsin inhibitor.

16 protein, alpha-tocopherol and Soybean Kunitz Trypsin Inhibitor.

17 cotyledon proteins, seed lectin, and Kunitz trypsin inhibitor.

18 less flexible crambin and bovine pancreatic trypsin inhibitor.

19 d inhibited by C1 inhibitor (C1-INH) or corn trypsin inhibitor.

20 itate the digestion of foods rich in natural trypsin inhibitors.

21 uman mesotrypsin is digestive degradation of trypsin inhibitors.

22 ibitor resistance and the ability to degrade trypsin inhibitors.

23 d a significant reduction in the activity of trypsin inhibitors.

24 soflavone forms and the residual activity of trypsin inhibitors.

25 rsion of isoflavones and the inactivation of trypsin inhibitors.

26 signal occurred upon administration of known trypsin inhibitors.

27 h as LTPs, omega5-gliadins and alpha-amylase/trypsin inhibitors.

28 es to the disulfide-linked 14-mer, sunflower trypsin inhibitor 1 are demonstrated.

29 esis of a functional analog of the Sunflower Trypsin Inhibitor 1.

30 ata B1, alpha-conotoxin Vc1.1, and sunflower trypsin inhibitor 1.

31 stances tested were tannins (20.7 mg g(-1)), trypsin inhibitor (1.45TIU mg g(-1)), nitrate (17 mg g(-

32 Sunflower trypsin inhibitor-1 (1, SFTI-1), isolated from sunflower

33 Sunflower trypsin inhibitor-1 (SFTI-1) and Momordica cochinchinens

34 the nature-derived cyclic peptide sunflower trypsin inhibitor-1 (SFTI-1) as a template for designing

35 Sunflower trypsin inhibitor-1 (SFTI-1) is a 14-amino acid cyclic p

36 thepsin G substrate sequences into sunflower trypsin inhibitor-1 (SFTI-1) produced a potent cathepsin

37 The plant-derived cyclic peptide, sunflower trypsin inhibitor-1 (SFTI-1), is a promising drug scaffo

38 d the recently discovered circular sunflower trypsin inhibitor-1 (SFTI-1).

39 the 14-amino acid backbone-cyclic sunflower trypsin inhibitor-1 scaffold to design a highly potent (

40 s) into the cyclic peptide SFTI-1 (sunflower trypsin inhibitor-1) and a heterodimeric 2S albumin.

41 s annuus PawS1 (preproalbumin with sunflower trypsin inhibitor-1) and provide new insights into the p

42 thetic inhibitor library (based on sunflower trypsin inhibitor-1) for characterizing the P2' specific

43 untreated samples contained a high level of trypsin inhibitor (2474.3-3271.4 trypsin inhibitor units

44 he antinutritional content of lectins (48%), trypsin inhibitor (57%), amylase inhibitor (49%) and phy

45 K) (85.4%), benzamidine (80.2%), and soybean trypsin inhibitor (75.6%) and partially inhibited by N-t

46 mparison to APIc and marked reduction in the trypsin inhibitor (85.97%) and lectin activity (100%) wa

47 blished using radiolabeled bovine pancreatic trypsin inhibitor (a non-hNE-binding peptide of similar

48 thway of coagulation was inhibited with corn trypsin inhibitor (a specific factor XIIa inhibitor with

49 was added to blood anticoagulated with corn trypsin inhibitor (a specific inhibitor of Factor XIIa w

50 disulfide proteins, namely bovine pancreatic trypsin inhibitor, a protein with three disulfides, and

51 n bone marrow cultures treated with soy bean trypsin inhibitor, a serine protease inhibitor, but this

52 Addition of MEK-1 inhibitors, trypsin inhibitors, a scrambled PAR-2 peptide, and silen

53 Pretreating duodenase with soybean trypsin inhibitor abolished DNA synthesis, confirming th

54 mesilate (acinar cell permeable) or soybean trypsin inhibitor (acinar cell nonpermeable) was adminis

55 caused a substantial reduction in urease and trypsin inhibitor activities and considerable decrease w

56 ared to the churi fractions (32-33%) and the trypsin inhibitor activities were found to be negligible

57 Trypsin inhibitor activity (TIA) was evaluated using a s

58 No major difference in the trypsin inhibitor activity among AF, Rs and Rc was obser

59 In gel trypsin inhibitor activity assays revealed a major clear

60 ong AF, Rs and Rc was observed; however, the trypsin inhibitor activity was drastically reduced in th

61 ith isoflavone conversions and reductions in trypsin inhibitor activity.

62 fied were beta-conglycinin, glycinin, Kunitz trypsin inhibitor, alcohol dehydrogenase, Gly m Bd 28K a

63 Feeding of soybean trypsin inhibitor and Aedes aegypti trypsin modulating o

64 duce susceptibility to inhibition by soybean trypsin inhibitor and antithrombin III.

65 r the first time a novel activity of soybean trypsin inhibitor and bovine aprotinin that they nick su

66 n-derived serine protease inhibitors soybean trypsin inhibitor and Bowman-Birk inhibitor inhibit prot

67 o globular proteins, i.e., bovine pancreatic trypsin inhibitor and equine metmyoglobin, on the confor

68 ulfide proteins, including bovine pancreatic trypsin inhibitor and hirudin.

69 Dual inhibition of FXIIa by corn trypsin inhibitor and kallikrein by soybean trypsin inhi

70 IR treatment had a more pronounced effect on trypsin inhibitor and lipoxygenase activities of soaked

71 Soybean trypsin inhibitor and phenylmethylsulphonylflouride comp

72 We illustrate them using bovine pancreatic trypsin inhibitor and present a new, detailed analysis o

73 y factor in the ability of bovine pancreatic trypsin inhibitor and similar inhibitors to resist hydro

74 two isoleucine residues in bovine pancreatic trypsin inhibitor and the four isoleucines in a cytochro

75 This increase was abolished by soybean trypsin inhibitor and was susceptible to carboxypeptidas

76 in that is uniquely resistant to polypeptide trypsin inhibitors and can cleave some inhibitors rapidl

77 t displays unusual resistance to polypeptide trypsin inhibitors and has been observed to cleave sever

78 ose, verbascose), inositol phosphates (IPs), trypsin inhibitors and lectins content.

79 ogous to the reactive site bond of canonical trypsin inhibitors and suggest that this surface loop mi

80 Endogenous trypsin inhibitors and upregulation of proteins includin

81 ase regulators (e.g., complement factors and trypsin inhibitors) and intracellular proteins (e.g., he

82 Model proteins were studied: ribonuclease A, trypsin inhibitor, and carbonic anhydrase, where the lat

83 pancreatic ribonuclease A, bovine pancreatic trypsin inhibitor, and chicken egg white lysozyme), as c

84 ved structures of barstar, bovine pancreatic trypsin inhibitor, and lysozyme show that even before an

85 rbonic anhydrase, alpha-lactalbumin, soybean trypsin inhibitor, and ovalbumin was separated using CEC

86 resis and ligand blot with biotinylated corn trypsin inhibitor, and positive bands were sequenced.

87 f the polar side-chains in bovine pancreatic trypsin inhibitor, and their 666 interaction energies, t

88 soybean trypsin inhibitor, bovine pancreatic trypsin inhibitor, antithrombin III, and alpha2-macroglo

89 Endogenous trypsin inhibitors are believed to inhibit protease acti

90 Phytic acid, tannins and trypsin inhibitor as antinutrients were detected.

91 hy and affinity chromatography by using corn trypsin inhibitor as ligand.

92 ticide residues (37 compounds), cyanide, and trypsin inhibitor, as well as Pb, Cd, nitrate, and nitri

93 lipids, and inactivation of lipoxygenase and trypsin inhibitors, as compared to isopropanol containin

94 mon dietary protein component, wheat amylase trypsin inhibitors (ATI), stimulate intestinal macrophag

95 BACKGROUND & AIMS: Wheat amylase-trypsin inhibitors (ATIs) are nutritional activators of

96 Wheat amylase-trypsin inhibitors (ATIs) are nutritional activators of

97 We identify the alpha-amylase/trypsin inhibitors (ATIs) CM3 and 0.19, pest resistance

98 Amylase-trypsin inhibitors (ATIs) have recently been identified

99 Amylase-trypsin inhibitors (ATIs) in wheat and related cereals a

100 Amylase trypsin inhibitors (ATIs), a component of wheat, activat

101 eat or gluten, with or without wheat amylase trypsin inhibitors (ATIs), for 1 week.

102 e precursor form of the Arabidopsis thaliana trypsin inhibitor (ATT(p), GenBank entry Z46816), a 68-r

103 th proteinaceous inhibitors, such as soybean trypsin inhibitor, basic pancreatic trypsin inhibitor, o

104 tion via (1) inclusion of the small molecule trypsin inhibitor benzamidine in the growth medium; or (

105 of BZiPAR fluorescence was inhibited by the trypsin inhibitor benzamidine.

106 Corn trypsin inhibitor binds to prekallikrein to prevent rPRC

107 Active monomers are inhibited by soybean trypsin inhibitor, bovine pancreatic trypsin inhibitor,

108 between a cleaved form of bovine pancreatic trypsin inhibitor (BPTI) and a catalytically inactive tr

109 esistance to inhibition by bovine pancreatic trypsin inhibitor (BPTI) and amyloid precursor protein K

110 eme models, represented by bovine pancreatic trypsin inhibitor (BPTI) and hirudin.

111 erent protein cavities, in bovine pancreatic trypsin inhibitor (BPTI) and in the I76A mutant of barna

112 onformational ensembles of bovine pancreatic trypsin inhibitor (BPTI) are accessed by replacing Cys 5

113 d-millisecond time scale in basic pancreatic trypsin inhibitor (BPTI) are investigated using nuclear

114 The 'core elements' in bovine pancreatic trypsin inhibitor (BPTI) are the two long strands of ant

115 trypsin and its inhibitor bovine pancreatic trypsin inhibitor (BPTI) as a model system.

116 uine metmyoglobin (Mb) and bovine pancreatic trypsin inhibitor (BPTI) at concentrations up to 0.4 and

117 n, G37A, on the surface of bovine pancreatic trypsin inhibitor (BPTI) destabilizes the protein by app

118 e inhibitors of the Kunitz-bovine pancreatic trypsin inhibitor (BPTI) family are ubiquitous biologica

119 Bovine pancreatic trypsin inhibitor (BPTI) forms an extremely stable and c

120 Tyr35-->Gly replacement in bovine pancreatic trypsin inhibitor (BPTI) has previously been shown to dr

121 The oxidative folding of bovine pancreatic trypsin inhibitor (BPTI) has served as a paradigm for th

122 sulfide folding pathway of bovine pancreatic trypsin inhibitor (BPTI) is characterized by the predomi

123 with a potent (Ki=0.4 nM) bovine pancreatic trypsin inhibitor (BPTI) mutant (5L15), a homolog of TFP

124 hibitors homologous to the bovine pancreatic trypsin inhibitor (BPTI) provide a suitable scaffold, bu

125 the Kunitz-type inhibitor bovine pancreatic trypsin inhibitor (BPTI) to probe fIXa reactivity in the

126 ng kinetics of a series of bovine pancreatic trypsin inhibitor (BPTI) variants with similar stabiliti

127 n the backbone dynamics of bovine pancreatic trypsin inhibitor (BPTI) were examined using 15N NMR rel

128 tially folded analogues of bovine pancreatic trypsin inhibitor (BPTI) with the proteolytically inacti

129 We have found that bovine pancreatic trypsin inhibitor (BPTI), a Kunitz protease inhibitor, i

130 acellular binding site for bovine pancreatic trypsin inhibitor (BPTI), a well-known inhibitor of vari

131 a small globular protein, bovine pancreatic trypsin inhibitor (BPTI).

132 lidated using ubiquitin and basic pancreatic trypsin inhibitor (BPTI).

133 including heparin and the bovine pancreatic trypsin inhibitor (BPTI).

134 disulfide intermediates of bovine pancreatic trypsin inhibitor (BPTI).

135 > L and F --> L mutants of bovine pancreatic trypsin inhibitor (BPTI).

136 s of two modified forms of bovine pancreatic trypsin inhibitor (BPTI).

137 ng experiment conducted on bovine pancreatic trypsin inhibitor (BPTI; 58 residues) suggested that if

138 tion of diffusion coefficients for lysozyme, trypsin inhibitor, BSA, and IgG both inside the hydrogel

139 nt rat corin was inhibited by small molecule trypsin inhibitors but not inhibitors for matrix metallo

140 e similar to the ADP-ribosylation of soybean trypsin inhibitor by ExoS.

141 ces covalent modification of the inter-alpha-trypsin inhibitor by TSG-6 and transfer of its heavy cha

142 endogenous CCK by administering a synthetic trypsin inhibitor, camostat (100 mg/kg).

143 PSTI-I to the pancreas increased endogenous trypsin inhibitor capacity by 190% (P <.01) in transgeni

144 Indian hedgehog protein], ITIH4 [inter-alpha-trypsin inhibitor chain H4], SAA2 [serum amyloid A2], AP

145 three different proteins, bovine pancreatic trypsin inhibitor, chymotrypsin inhibitor 2, and barnase

146 fective at blocking the chymotrypsin-soybean trypsin inhibitor complex and that the mechanism involve

147 we demonstrate that benzamidine and soybean trypsin inhibitor-conjugated Sepharose beads, which bind

148 The trypsin inhibitors content was almost abolished by canni

149 site of ribonuclease and the K15 site of the trypsin inhibitor could be readily acylated by the enzym

150 or plasma (PPP), either with or without corn trypsin inhibitor (CTI) to prevent contact activation, o

151 reagent and contact pathway inhibitor (corn trypsin inhibitor, CTI) to develop a reproducible thromb

152 annexin A1 protein grafted into a sunflower trypsin inhibitor cyclic scaffold.

153 SPINK1, a secretory trypsin inhibitor, demonstrated potential as a diagnosti

154 however, partially reduced bovine pancreatic trypsin inhibitor (des(14-38)) is not.

155 d SPINK1 or other nonpermeable proteinaceous trypsin inhibitors did not restore normal secretion of t

156 ch domains, a von Willebrand D domain, and a trypsin inhibitor domain.

157 ase inhibitor, Enterolobium contortisiliquum trypsin inhibitor (EcTI), on the adhesion, migration, an

158 onan and the heavy chains of the inter-alpha-trypsin inhibitor family.

159 hat LTI is a member of the bovine pancreatic trypsin inhibitor family.

160 Bovine pancreatic trypsin inhibitor follows the same general phase behavio

161 enzymatic activity of trypsin and to screen trypsin inhibitors for their inhibition efficiency.

162 itor-II (MCoTI-II), a structurally divergent trypsin inhibitor from Momordica cochinchinensis that al

163 A potent trypsin inhibitor from Tityus obscurus scorpion venom wa

164 families: cyclotides and circular sunflower trypsin inhibitors from the kingdom of plants and the Am

165 plete removal of guanidine, which is a known trypsin inhibitor, from the digestion buffer.

166 Loss of trypsin inhibitor function may have similar effects.

167 her KLK5 activity by the inhibitor sunflower trypsin inhibitor G, restoration of DSG1 expression and

168 % of these individuals have mutations of the trypsin inhibitor gene (SPINK1) or the cystic fibrosis t

169 c trypsinogen gene, the pancreatic secretory trypsin inhibitor gene, and the cystic fibrosis transmem

170 enoxaparin is greatest for basic pancreatic trypsin inhibitor (>10-fold), followed by the second tis

171 Blockade of FXII by corn trypsin inhibitor had a significant inhibitory effect on

172 phases carrying long alkyl chains or soybean trypsin inhibitor have been prepared for use in HPLC sep

173 ; and (c) a cleavage fragment of inter-alpha-trypsin inhibitor heavy chain H4 (up-regulated).

174 ng a positive regulator of IL-6, Inter-alpha-trypsin inhibitor-heavy chain-4 (ITIH4), resulted in red

175 inhibitors (lkiL-1, lkiL-2, lkiL-3), potato trypsin inhibitor I (ptiIL-1), serpins (serpL-1), cystat

176 her increased levels of pancreatic secretory trypsin inhibitor-I (PSTI-I) in mice could prevent secre

177 Inter-alpha-trypsin inhibitor (IaI) is an abundant serum protease in

178 Inter-alpha-trypsin inhibitor (IaI) is an abundant serum protein.

179 ent linkage between HC1 from the inter-alpha-trypsin inhibitor (IalphaI) and HA, purified from the hu

180 g demonstrates components of the inter-alpha-trypsin inhibitor (IalphaI) complex in both coat-like an

181 Inter-alpha-trypsin inhibitor (IalphaI) is a complex comprising two

182 Additionally, the inter-alpha-trypsin inhibitor (IalphaI), a proteoglycan essential fo

183 a complex with a serine protease inter-alpha-trypsin inhibitor (IalphaI), increasing the protease inh

184 which the heavy chains (HCs) of inter-alpha-trypsin inhibitor (IalphaI)-related proteins are covalen

185 methyl acetate (IC(50) = 1 microm), and corn trypsin inhibitor (IC(50) = 40 nm).

186 cyclic miniprotein Momordica cochinchinensis Trypsin Inhibitor II (MCoTI-II) (34 amino acids) is a po

187 tor-1 (SFTI-1) and Momordica cochinchinensis trypsin inhibitor-II (MCoTI-II) are potent protease inhi

188 hips of SFTI-1 and Momordica cochinchinensis trypsin inhibitor-II (MCoTI-II), a structurally divergen

189 nhibitors based on Momordica cochinchinensis trypsin inhibitor-II.

190 iation of chymotrypsin and bovine pancreatic trypsin inhibitor in a solution mixture and simultaneous

191 antibodies, such as antipancreatic secretory trypsin inhibitor in Ela1-LTab mice.

192 (2-furoyl)quinoline-2-carboxaldehyde labeled trypsin inhibitor in one-dimensional separation; detecti

193 The presence of a trypsin inhibitor in the perivitelline fluid compartment

194 g monomers and decamers of bovine pancreatic trypsin inhibitor in the presence of dextran up to a mac

195 eted protein, we expressed bovine pancreatic trypsin inhibitor in yeast.

196 roven, and the role of endogenous pancreatic trypsin inhibitors in acute pancreatitis is unknown.

197 ate, nitrite, cyanide, oxalate, phytate, and trypsin inhibitor) in tubers of Jerusalem artichokes-Kae

198 Bovine pancreatic trypsin inhibitor is a single domain, 58-amino acid poly

199 activity of factor IXa with basic pancreatic trypsin inhibitor is enhanced by low molecular weight he

200 erted the specificity of antithrombin from a trypsin inhibitor (k(assoc) = 2 x 10(5) M(-1) s(-1)) to

201 d found evidence for radiation of the Kunitz trypsin inhibitor (KTI) gene family within winged bean.

202 taining copy number variations of the Kunitz trypsin inhibitor (KTI) genes.

203 ructures of P1 (Lys+)15 of bovine pancreatic trypsin inhibitor (Kunitz) ( and ) and of the P1 (Lys+)1

204 vomucoid third domain, and bovine pancreatic trypsin inhibitor (Kunitz) are all standard mechanism, c

205 t in sharp contrast to the bovine pancreatic trypsin inhibitor (Kunitz) data.

206 ting the presence of three bovine pancreatic trypsin inhibitor/Kunitz domains and its high homology w

207 tail containing AEBSF, aprotinin, pancreatic trypsin inhibitor, leupeptin, antipain, and EDTA could n

208 between Cys14 and Cys38 of bovine pancreatic trypsin inhibitor lies on the surface of the inhibitor a

209 cysteine-rich motif with similarities to the trypsin inhibitor-like (TIL) domains of small serine pro

210 The smaller C8-3, TIL3 (trypsin inhibitor-like 3), and E3 modules pack through s

211 ein is composed of a signal sequence and two trypsin inhibitor-like domains and likely functions as a

212 erpins, Kazal-type inhibitors, cystatins and trypsin inhibitor-like molecules.

213 ontains 13 zinc-finger domains and has three trypsin inhibitor-like, cysteine-rich domains and is wid

214 mblies include von Willebrand D, 8-cysteine, trypsin inhibitor-like, E or fibronectin type 1-like dom

215 D' consists of 2 domains, trypsin-inhibitor-like (TIL') and E', of which the TIL'

216 Effects of IR treatment on urease, trypsin inhibitor, lipoxygenase-1 and lipoxygenase-3 act

217 oduce significant amounts of a novel Lymnaea trypsin inhibitor (LTI), a second peptide that was purif

218 proteins (ovalbumin, ribonuclease A, soybean trypsin inhibitor, lysozyme, and beta-lactoglobulin A an

219 l tissues where its resistance to endogenous trypsin inhibitors may permit prolonged signaling.

220 ar dynamics simulations on the cysteine-rich trypsin inhibitor MCoTI-II with three disulfide bridges.

221 ajor receptor for hyaluronan) or inter-alpha-trypsin inhibitor (molecule that facilitates hyaluronan

222 the finding and characterization of a novel trypsin inhibitor, named panulirin, isolated from the he

223 The P1 residue Arg-15 (bovine pancreatic trypsin inhibitor numbering) in KD1 interacts with Asp-1

224 containing up to 0.12 g/mL bovine pancreatic trypsin inhibitor or 0.2 g/mL metmyoglobin.

225 e degrading protease is inhibited by soybean trypsin inhibitor or by low concentrations of blood plas

226 , elastin, beta-casein, plasminogen, soybean trypsin inhibitor, or Bowman-Birk inhibitor.

227 soybean trypsin inhibitor, basic pancreatic trypsin inhibitor, ovomucoid turkey inhibitor, and Bowma

228 Cell death was blocked by the trypsin inhibitor Pefabloc but not by the pancaspase inh

229 o-Prolinal or plasma kallikrein with soybean trypsin inhibitor, Pro-Phe-Arg-chloromethylketone or PKS

230 in the cleavage of Kunitz-bovine pancreatic trypsin inhibitor protease inhibitors by mesotrypsin, fi

231 trypsinogens I and II, pancreatic secretory trypsin inhibitor (PSTI) and plasminogen binding protein

232 on mutations of CFTR and of genes encoding a trypsin inhibitor (PSTI) and trypsinogen (PRSS1).

233 Pancreatic secretory trypsin inhibitor (PSTI) is a serine protease inhibitor,

234 e) ECaSt/PDI augmented the bovine pancreatic trypsin inhibitor reactivation rate.

235 Soybean trypsin inhibitor reduced secretion to background levels

236 Maximum trypsin inhibitor reduction in IR-treated samples was 95

237 t effective in inactivating lipoxygenase and trypsin inhibitors, retarding lipid oxidation as well as

238 n the crystal structure of bovine pancreatic trypsin inhibitor revealed that KD1 formed a more energe

239 ation of the small protein bovine pancreatic trypsin inhibitor reveals that its main conformations ha

240 gen, pepsinogen, lysozyme, bovine pancreatic trypsin inhibitor, ribonuclease A, and T4 lysozyme) were

241 ld, similar to those found in Kunitz soybean trypsin inhibitors, ricin-like toxins, plant agglutinins

242 eactive-site peptide bond of the Kunitz-type trypsin inhibitor SBTI, and irreversibly degraded the Ka

243 o natural trypsin inhibitors such as soybean trypsin inhibitor (SBTI) or human pancreatic secretory t

244 Additionally, we found that when soybean trypsin inhibitor (SBTI), was added to rat heart effluen

245 ) in the presence and the absence of soybean trypsin inhibitor (SBTI; 100 units/g pretreated skin) fo

246 he dramatic enhancement of bovine pancreatic trypsin inhibitor self-association can be quantitatively

247 Protease inhibitors, such as trypsin inhibitor, serum alpha-1 antitrypsin, or liver a

248 Gabexate mesilate as well as soybean trypsin inhibitor significantly decreased TAP levels in

249 se changes are mirrored in bovine pancreatic trypsin inhibitor solubility where the typical salting o

250 n the gene encoding the pancreatic secretory trypsin inhibitor SPINK1 further increase the risk of pa

251 or (2) cotransfection with the physiological trypsin inhibitor SPINK1; or (3) by mutation of the cata

252 hibitor (SBTI) or human pancreatic secretory trypsin inhibitor (SPINK1).

253 We also analyzed the soybean trypsin inhibitor (STI) gene family, important plant def

254 s affects the secondary structure of soybean trypsin inhibitor (STI).

255 The high-pH trypsin-inhibitor structures suggest that His57 is proto

256 nized for its peculiar resistance to natural trypsin inhibitors such as soybean trypsin inhibitor (SB

257 studies of factor IXa with basic pancreatic trypsin inhibitor suggest that binding of this inhibitor

258 se A, microbial ribonuclease, and pancreatic trypsin inhibitor, suggesting that an ongoing surveillan

259 not motif-containing cyclotides: Mobius (M), trypsin inhibitor (T), and bracelet (B).

260 laminin receptor (67LR) and tumor-associated trypsin inhibitor (TATI), had previously been associated

261 plex between factor IXa and basic pancreatic trypsin inhibitor that is facilitated by enoxaparin bind

262 itz-type inhibitor domains: basic pancreatic trypsin inhibitor, the Kunitz inhibitor domain of protea

263 by the complex of kallikrein and pancreatic trypsin inhibitor, the overall stability results from th

264 The determination of trypsin inhibitor (TI) activity is of importance to eval

265 r II (MCoTI-II) (34 amino acids) is a potent trypsin inhibitor (TI) and a favored scaffold for drug d

266 showed that purified CPB, in the presence of trypsin inhibitor (TI), can reproduce type C pathology i

267 sing a ladder of small-to-mid mass proteins (Trypsin Inhibitor (TI); Ovalbumin (OVA); Bovine Serum Al

268 n of CCK or intragastric administration of a trypsin inhibitor to elicit endogenous CCK release was f

269 fer of heavy-chain proteins from inter-alpha-trypsin inhibitor to hyaluronan to form heavy-chain prot

270 Whole blood supplemented with corn trypsin inhibitor (to inhibit factor XIIa) was perfused

271 let-rich plasma (PRP) supplemented with corn trypsin inhibitor (to shut down contact activation) was

272 d could be applied to preclinically optimize trypsin inhibitors towards intrapancreatic target inhibi

273 Human blood (corn trypsin inhibitor treated [4 mug/mL]) was tested by micr

274 in endothelial cells in the presence of corn trypsin inhibitor treated human plasma devoid of platele

275 Corn trypsin inhibitor-treated blood was fractionated to yiel

276 Cathepsin G addition to corn trypsin inhibitor-treated PFP produced little thrombin u

277 r rate of 100-500 s(-1)) of recalcified corn trypsin inhibitor-treated whole blood or platelet rich p

278 rfusion (wall shear rate, 200 s(-1)) of corn trypsin inhibitor-treated whole blood over a 250-mum lon

279 otease inhibitor lymphoepithelial Kazal-type trypsin inhibitor type 1; and the fatty acid transporter

280 gh level of trypsin inhibitor (2474.3-3271.4 trypsin inhibitor units per gramme (TIU/g) of flour) and

281 means of hydrogen bonds in Cucurbita maxima trypsin inhibitor-V (CMTI-V), a potato I family member.

282 ding random mutations in a bovine pancreatic trypsin inhibitor variant containing a small generic tag

283 C higher than the original bovine pancreatic trypsin inhibitor variant.

284 Soybean trypsin inhibitor was added to serum before injections t

285 Soybean trypsin inhibitor was functionalized with N-(4-pentynoyl

286 trypsin inhibitor and kallikrein by soybean trypsin inhibitor was necessary for abolishing RBC-MV-in

287 mice, although the CCK secretory response to trypsin inhibitor was retained.

288 the allergen Tri a 30 (the CM3 alpha-amylase/trypsin inhibitor) was quantified in durum wheat salt so

289 rresponding to soybean agglutinin and Kunitz trypsin inhibitor were identified based on the statistic

290 alpha-Amylase/trypsin inhibitors were also found to be involved in whe

291 The human RSL served as a trypsin inhibitor when supported by mouse scaffold seque

292 Soy bean trypsin inhibitor, when added to mast cell releasates, p

293 acid, tannins, flavonoids, HCN, oxalate and trypsin inhibitor which were observed in the range of 99

294 oncentrations of verbascoside, lignin and/or trypsin inhibitors, which decreased larval survival and/

295 We have adapted the corn-trypsin inhibitor whole-blood model to include EA.hy926

296 Bovine pancreatic trypsin inhibitor with (Lys+)15 at P1 binds to chymotryp

297 igested beta-casein poorly and bound soybean trypsin inhibitor with 10-fold decreased affinity.

298 iochemical assays, reveals that it encodes a trypsin inhibitor with sequence and structural similarit

299 Moreover, pLR is a highly potent trypsin inhibitor, with Ki values in the nanomolar range

300 ne), and compare them with the corresponding trypsin-inhibitor-Zn2+ complexes.